Angiogenesis is a hallmark of HCC progression, with vascular endothelial growth factor (VEGF) and its receptor (VEGFR) playing pivotal roles in regulating both tumor angiogenesis and immunosuppression. This evidence concerns the gene KDR and neoplasm.